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Abstract
Human milk contains higher levels of gangliosides when compared to infant formula. Gangliosides play a role 
in neuronal growth, migration, maturation, sinaptogenesis, and myelination. Seven of the identified gangliosides 
(GM1, GM2, GM3, GD3, GD1a, GD1b, and GT1b) are dominant gangliosides with different specific functions. 
Thus, the aim of the study was to understand the effects of ganglioside-enhanced diet and to compare the spectrum 
patterns of those seven classes of serum gangliosides in infants consuming standard infant formula (IF group), 
ganglioside-fortified infant formula (GA group) and exclusive breastfeeding (BF group). This study used liquid 
chromatography–mass spectrometry (LC-MS) method. This was a prospective study involving 30 infants in IF 
group, 29 in GA group and 32 in BF group. Subject recruitment was performed using consecutive admission 
approach from March 2008 to February 2009 in Bandung. Statistical analyses using Wilcoxon test showed that 
there was a significant change in the spectrum patterns of GD3, GM1, GM2 and GT1b in IF group; of GD1a, GM1 
and GM2 in GA group and of GD1a, GD1b, GM1 and GM3 in BF group. It is concluded that ganglioside-enriched 
diet extends spectrum patterns of gangliosides especially in seven of them, i.e. GM1, GM2, GM3, GD3, GD1a, 
GD1b, and GT1b, in 6-month old infants. [MKB. 2012;44(4):240–44]..
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Perubahan Pola Spektrum Gangliosida Serum yang Diinduksi Makanan 
pada Bayi Usia 6 Bulan
Abstrak
Air susu ibu (ASI) mengandung gangliosida yang kadarnya lebih tinggi dibandingkan dengan susu formula. 
Gangliosida berperan dalam pertumbuhan, migrasi, maturasi saraf, sinaptogenesis, dan mielinisasi. Tidak 
kurang dari 100 tipe gangliosida telah ditemukan, tujuh di antaranya (GM1, GM2, GM3, GD3, GD1a, GD1b, 
dan GT1b) merupakan kelas utama dengan fungsi yang berbeda. Penelitian ini bertujuan untuk mengetahui 
efek penambahan diet gangliosida serta membandingkan pola spektrum tujuh kelas gangliosida serum tersebut 
pada bayi yang mengonsumsi susu formula standar (kelompok infant formula/IF), susu formula difortifikasi 
gangliosida (kelompok GA), dan ASI eksklusif (kelompok breastfeeding/BF). Penelitian ini menggunakan metode 
liquid chromatography-mass spectrometry (LC-MS) untuk menghitung kadar ketujuh kelas gangliosida tersebut. 
Penelitian ini adalah penelitian prospektif yang melibatkan 30 bayi kelompok IF, 29 bayi kelompok GA, dan 32 
bayi kelompok BF. Perekrutan subjek penelitian dilakukan dengan cara consecutive admission dari bulan Maret 
2008 sampai bulan Februari 2009 di Bandung. Analisis statistik tes Wilcoxon menunjukkan perubahan bermakna 
pada pola spektrum GD3, GM1, GM2 dan GT1b pada kelompok IF; GD1a, GM1, dan GM2 pada kelompok GA; 
GD1a, GD1b, GM1, dan GM3 pada kelompok BF. Kesimpulan, penambahan diet gangliosida akan meningkatkan 
7 spektrum gangliosida yaitu GM1, GM2, GM3, GD3, GD1a, GD1b, dan GT1b pada anak usia 6 bulan. [MKB. 
2012;44(4):240–44].
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Introduction
Gangliosides, a large family of complex lipids 
that are abundant in the brain, have been shown 
to affect neuronal plasticity during development, 
adulthood, and aging and are considered to be 
possible therapeutics.1 Gangliosides in human 
milk and infant milk formula are considered as 
one of the bioactive components in human infant 
nutrition and have an important role during early 
infancy by modifying the intestinal microflora 
and promoting the development of intestinal 
immunity in neonates.2
Dietary gangliosides will produce increased 
ganglioside levels in the blood, as well as in 
other organs including the brain.3 Gangliosides 
are metabolized further via several routes, one of 
which involves direct glycosylation in the Golgi 
apparatus. This metabolism results in different 
classes of gangliosides (GM1, GM2, GM3, GD3, 
GD1a, GD1b, and GT1b) that have their own 
specific functions.3
The aim of this study was to compare the 
spectrum patterns of serum gangliosides due to 
different functions of each ganglioside class in 
infants who had consumed breastmilk, standard 
infant formula or ganglioside-fortified infant 
formula. The study has received approval from 
the Ethics Committee of Faculty of Medicine, 
Universitas Padjadjaran, Dr. Hasan Sadikin 
General Hospital Bandung. Written informed 
consent from parents was also obtained.
Methods
An analytic prospective study was conducted 
in a number of public health centers in Bandung. 
Subjects were selected based on consecutive 
admission sampling method. All subjects were 
healthy term infants, singleton births, with a birth 
weight of ≥2,500 g and no perinatal complications.
Ninety one  healthy term infants, 2 to 8 
weeks old, were recruited. Subjects of the study 
were divided into three groups: a group of 
infants consuming standard infant formula (IF 
group, 30 infants), a group of infants consuming 
ganglioside-fortified infant formula (GA group, 
29 infants) and a group of exclusively-breastfed 
infants (BF group, 32 infants). The volume of 
breastmilk and formula consumed was quantified 
regularly.
In this study, we used liquid chromatography–
mass spectrometry (LC-MS) methods to 
measure the ganglioside composition in the 
serum. LC-MS offers improved sensitivity and 
selectivity over the more traditional thin layer 
chromatography (TLC) and high performance 
liquid chromatography (HPLC) methods for 
ganglioside detection. Five mL of blood was 
obtained from the sample and serum, which were 
then analyzed at the Fonterra Research Centre, 
Palmerson North, New Zealand.4
Briefly, the blood lipids were extracted using a 
Svennerholm and Fredman extraction protocol.3 
The HPLC analysis was performed on an Agilent 
APS-2  Hypersil hydrophilic column (150 mm 
x 2.1 mm, 3 µm, Thermo Electron Corporation, 
Waltham, MA) coupled to an APS-2 guard 
column (10 mm x 2.1 mm inner diameter). The 
gangliosides were separated with an acetonitrile: 
ammonium acetate buffer gradient. The eluate 
from the HPLC system was introduced into an 
LTQ-Orbitrap™ mass spectrometer using an ESI 
probe inlet. MS data acquisition was carried out 
using the LTQ-Orbitrap™ mass spectrometer 
scanning in negative ion mode with a resolution 
of 30.000 over 700-1.650 m/z. The system was 
calibrated with ganglioside standards obtained 
from Matreya, LLC. The resolving power of the 
LTQ-Orbitrap™ mass spectrometer was used 
for post analysis filtering for known masses of 
ganglioside species present within each class of 
ganglioside measured.
The spectrum patterns of serum gangliosides 
were quantified at baseline and again at 6 months, 
using LC−MS as described in Fong et al.4  Data 
were analyzed with Wilcoxon test, using SPSS 
version 17.0.
Results
At the beginning of the trial, 91 infants met 
the inclusion criteria of the study and were split 
into three groups: a group of infants consuming 
standard infant formula (IF group, 35 infants), a 
group of infants consuming ganglioside-fortified 
infant formula (GA group, 35 infants), and a group 
of  infants receiving exclusive breastfeeding (BF 
group, 40 infants). The characteristics of these 
infants  were presented in Table.
During the trial period (up to six months old) 
19 infants dropped out: 5 from IF group, 6 from 
GA group and 8 infants from BF group. Data 
collection was performed twice a week by field 
assistants. The data consisted of frequency and 
duration of breastfeeding, fortified infant formula 
and standard infant formula consumption. using a 
structured questionnaire (Figure 1).
Using LC-MS as described in Fong et al.,4 the 
subject’s serum ganglioside spectrum patterns 
were quantified at baseline and again at 6 months 
(Figure 1)
There was a change from baseline to 6 months 
in the spectrum patterns of GD3 (p=0.035); GM1 
(p<0.001); GM2 (p<0.001); GT1b (p=0.005). 
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In GA group, a change in the spectrum patterns 
occurs in GD1a (p=0.005); GM1 (p<0.001); GM2 
(p<0.001). In BF group, there was a change in 
the spectrum patterns of GD1a (p=0.003), GD1b 
(p=0.033), GM1 (p<0.001), and GM3 (p<0.001) 
(Figure 2).
Discussion
Gangliosides are important substances in 
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Figure 2 Spectrum Patterns of Serum Gangliosides at Baseline and at 6 Months
Table Baseline Characteristics of Infants
Characteritics
Standard  Infant 
Formula/IF Group
(n=30)
Ganglioside-fortified 
Infant Formula/GA 
Group
 (n=29)
Exclusively-breastfed 
Infant/BF Group
(n=32)
Sex 
Male 18 15 18
Female 12 14 14
Birth weight (kg) 
Male 3.21 (2.50–3.90) 3.18 (2,60–3.80) 3.13 (2.60–3.80)
Female 3.04 (2.60–3.60) 2.99 (2.50–3.70) 3.09 (2.60–3.85)
Age (weeks) 4.37 (2–8) 4.26 (2–8) 2.10 (2–4)
Figure 1 Total Volume Breastmilk and Formula Intake
Note: per 100 mL fortified infant formula= 1.71 mg gangliosides per 100 mL standard formula= 0.54 
mg gangliosides
0–1 mo      1–2 mo     2–3 mo      3–4 mo     4–5 mo      5–6 mo
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cells and play some biological functions. There 
are at least 100 types of ganglioside structures 
which have been found in the last 20 years, and 
GM, GD and GT classes are dominant in brain, 
making up approximately 80−90% of the total 
mass of gangliosides.5 Gangliosides are also 
found in daily food such as in mammalian milk, 
eggs and meat products like liver, but not in plant 
-based foods.3 Amazingly, human breastmilk is 
the richest source of gangliosides.6 High level of 
GD3 gangliosides is found in human breastmilk 
colostrum and also in developing tissues.
Cow milk is used as the main source for 
infant formula production since the ganglioside 
distribution in cow milk is similar to that in 
human breastmilk although the levels in cow 
milk is a much lower. It is possible to restore 
the levels of gangliosides in infant formula by 
using an enriched preparation of the complex 
milk lipids from the milk fat globule membrane 
which has a higher proportion of gangliosides. 
Addition of this milk lipid ingredient into the 
infant formula formulation raises ganglioside 
levels to more closely match the levels reported 
for human breastmilk. Gangliosides injected 
into experimental animals would appear in the 
forms of misel, monometer and oligomer before 
they are absorbed by cells in solution.7 Serum 
Gangliosides are considered to appear in a form 
of one of those three.
Dietary gangliosides would arrive in digestive 
system in the same forms after coming through 
acid condition along the infant’s gut. Dietary 
gangliosides are absorbed by small intestines and 
transported to different receptor membranes in the 
body.8 After absorbed by small intestines, dietary 
gangliosides may be reformed in the enterocyte, 
which will induce a change in the spectrum 
patterns of gangliosides in membranes. These 
gangliosides then come into blood circulation 
and finally cross the blood-brain barrier (BBB) 
(Figure 3).
In this study, a change in the spectrum patterns 
of some ganglioside classes in all groups was 
found at baseline and 6 months old (Figure 2). 
As mentioned above, each class of gangliosides 
has different functions. Concerning endogenous 
gangliosides, neuronal GD1a and GT1b were 
found to function as ligands for myelin-associated 
glycoprotein, promoting myelin stability and 
controlling nerve regeneration.8Another specific 
function of ganglioside GT1b in neurons that has 
been  identified was p58, a brain-specific, sodium-
dependent inorganic phosphate contrasporter 
and a GT1b-binding protein.10 In cell cultures 
of primary neurons and neuroblastoma cells, 
GM1 was discovered to be upregulated in the 
nuclear membrane following Ca2+-elevating 
stimulation and facilitates the efflux of nuclear 
Ca2+.12 Referring to data from genetic diseases, 
Tay-Sachs disease and related neuronal storage 
disorders−ganglioside GM2 is strongly suggested 
to be specifically involved in pyramidal neuron 
dendritogenesis11 although the mechanisms are 
still unknown. Likewise, a specific functional 
involvement of O-acetylated GD3 and GD2 in 
Figure 3 Uptake of Dietary Gangliosides by the Body3
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neuronal migration in the mammalian brain is 
most likely. However, the mechanisms are not yet 
clarified in this case.12
In conclusion, ganglioside-enhanced diet 
extends ganglioside spectrum patterns especially 
in seven of them, i.e. GM1, GM2, GM3, GD3, 
GD1a, GD1b, and GT1b in 6-months old infants.
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